| Quarterly Financials | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
Revenue  | 444 | 927 | 1,200 | 1,606 | 974 | 1,695 | 1,463 | 1,816 | 1,427 | 1,211 | 1,205 | 1,178 | 1,014 | 1,025 | 901 | 1,063 | 1,156 | 1,004 | 1,068 | 1,165 |
| Expenses | 459 | 794 | 819 | 1,000 | 809 | 1,327 | 1,099 | 1,461 | 1,298 | 1,096 | 1,110 | 1,049 | 1,031 | 942 | 895 | 1,030 | 1,021 | 967 | 1,026 | 1,114 |
| EBITDA | -15 | 133 | 382 | 606 | 165 | 368 | 364 | 355 | 129 | 115 | 95 | 128 | -17 | 83 | 6 | 34 | 136 | 37 | 43 | 51 |
| Operating Profit % | -4 % | 14 % | 25 % | 25 % | 16 % | 21 % | 24 % | 19 % | 8 % | 8 % | 7 % | 8 % | -3 % | 5 % | -1 % | 2 % | 11 % | 3 % | 3 % | 3 % |
| Depreciation | 31 | 32 | 33 | 36 | 31 | 33 | 33 | 40 | 41 | 33 | 35 | 34 | 33 | 35 | 38 | 46 | 45 | 45 | 47 | 62 |
| Interest | 107 | 121 | 114 | 92 | 100 | 149 | 37 | 35 | 36 | 40 | 40 | 38 | 44 | 39 | 47 | 51 | 59 | 57 | 59 | 62 |
| Profit Before Tax | -153 | -18 | 237 | 481 | 34 | 186 | 295 | 280 | 53 | 42 | 21 | 57 | -93 | 9 | -78 | -63 | 32 | -65 | -63 | -73 |
| Tax | -51 | -6 | 77 | 117 | 5 | 35 | 59 | 49 | 12 | 3 | -7 | 10 | -29 | -17 | 11 | -32 | 8 | -34 | -14 | -19 |
| Net Profit | -102 | -12 | 160 | 364 | 29 | 151 | 237 | 232 | 41 | 39 | 27 | 46 | -64 | 26 | -89 | -31 | 24 | -31 | -49 | -54 |
| EPS in ₹ | 0.00 | -0.89 | 11.93 | 27.16 | 2.15 | 10.51 | 14.98 | 14.65 | 2.57 | 2.44 | 1.72 | 2.91 | -4.05 | 1.65 | -5.65 | -1.97 | 1.51 | -1.95 | -3.06 | -3.39 |
Chemplast Sanmar
440.25
+0.15
(0.03%)
Market Cap
6,960.80 Cr
EPS
-10.02
PE Ratio
-
Dividend Yield
0.00 %
Industry
Chemicals52 Week High
633.90
52 Week Low
379.00
PB Ratio
12.46
Debt to Equity
5.21
Sector
Commodity Chemicals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from3 analysts
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
900.40 | #1 22,938.30 | 79.97 | #1 15,707.00 | -7.64 | 449 | 94.17 | 66.32 | |
1,355.40 | 17,110.30 | 18.33 | 8,798.90 | -22.71 | 457 | 20.83 | 59.82 | |
547.85 | 8,050.10 | 13.49 | 8,398.90 | -20.68 | 485 | 62.31 | 68.25 | |
440.25 | #4 6,960.80 | - | #4 4,003.40 | #7 -20.27 | #9 -158 | #10 -74.28 | 59.02 | |
633.85 | 6,069.40 | #1 9.73 | 3,498.80 | -23.68 | #1 794 | 20.34 | 58.53 | |
850.20 | 5,424.40 | - | 21.50 | #1 10,650.00 | 2 | 62.50 | 56.03 | |
602.30 | 4,423.60 | - | 3,896.70 | -14.52 | -237 | #1 119.05 | 44.71 | |
80.98 | 3,671.70 | 23.34 | 1,099.90 | 9.90 | 146 | -11.99 | 41.34 | |
3,116.15 | 3,108.40 | 35.26 | 385.20 | 0.60 | 53 | 78.74 | 50.05 | |
249.98 | 2,559.50 | - | 2,102.50 | -2.77 | -39 | 31.22 | 47.77 |
Automatic Screeners on ScanX
Forecast
Actual
Growth Rate
Revenue Growth
-20.27 %
Net Income Growth
-204.01 %
Cash Flow Change
-168.91 %
ROE
-213.66 %
ROCE
-114.05 %
EBITDA Margin (Avg.)
-75.62 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 3,802 | 4,108 | 4,487 | 5,602 | 5,837 | 6,030 |
| Fixed Assets | 2,108 | 2,174 | 3,148 | 3,259 | 3,186 | 3,907 |
| Current Assets | 1,535 | 443 | 1,275 | 2,261 | 2,146 | 1,841 |
| Capital Work in Progress | 117 | 8 | 25 | 34 | 402 | 190 |
| Investments | 1,159 | 1,458 | 0 | 0 | 0 | 0 |
| Other Assets | 418 | 467 | 1,314 | 2,309 | 2,249 | 1,934 |
| Total Liabilities | 3,802 | 4,108 | 4,487 | 5,602 | 5,837 | 6,030 |
| Current Liabilities | 692 | 428 | 1,998 | 2,256 | 2,234 | 2,484 |
| Non Current Liabilities | 610 | 1,767 | 2,838 | 1,642 | 1,744 | 1,846 |
| Total Equity | 2,500 | 1,913 | -350 | 1,705 | 1,859 | 1,701 |
| Reserve & Surplus | 1,795 | 1,846 | -451 | 1,592 | 1,745 | 1,587 |
| Share Capital | 67 | 67 | 67 | 79 | 79 | 79 |
Cash Flow
| Cash Flow | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | 27 | 211 | 696 | 111 | -387 |
| Investing Activities | -438 | 2,152 | 108 | -217 | -524 |
| Operating Activities | 166 | 1,076 | 901 | 355 | -245 |
| Financing Activities | 298 | -3,017 | -313 | -27 | 382 |
Share Holding
| % Holding | Aug 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
| Promoter | 54.99 % | 54.99 % | 54.99 % | 54.99 % | 54.99 % | 54.99 % | 54.99 % | 54.99 % | 54.99 % | 54.99 % | 54.99 % | 54.99 % | 54.99 % | 54.99 % | 54.99 % | 54.99 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 11.60 % | 0.00 % | 10.83 % | 11.27 % | 13.41 % | 13.19 % | 13.27 % |
| DIIs | 19.31 % | 26.23 % | 24.73 % | 24.19 % | 24.04 % | 25.91 % | 26.81 % | 27.81 % | 26.64 % | 26.94 % | 27.40 % | 28.15 % | 28.39 % | 25.74 % | 25.82 % | 25.81 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 7.26 % | 5.64 % | 7.54 % | 7.48 % | 7.45 % | 7.14 % | 6.61 % | 6.63 % | 4.71 % | 4.41 % | 4.32 % | 4.11 % | 3.80 % | 4.53 % | 4.62 % | 4.57 % |
| Others | 18.44 % | 13.14 % | 12.74 % | 13.34 % | 13.52 % | 11.96 % | 11.60 % | 10.57 % | 13.66 % | 2.07 % | 13.29 % | 1.92 % | 1.55 % | 1.33 % | 1.38 % | 1.36 % |
| No of Share Holders | 0 | 2,64,333 | 1,20,644 | 1,10,839 | 1,02,409 | 1,02,634 | 1,05,411 | 99,608 | 92,610 | 93,594 | 90,184 | 85,649 | 74,800 | 72,772 | 70,994 | 68,751 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
No dividends have been distributed by the company in the past 10 years
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 07 Aug 2025 |  Annual General Meeting | NA | 07 Aug 2025 | 399.05 | 439.60 |
| 13 May 2025 |  Quarterly Result Announcement | NA | 13 May 2025 | 389.85 | 399.05 |
| 07 Feb 2025 | Quarterly Result Announcement | NA | 07 Feb 2025 | 466.75 | 474.80 |
| 05 Nov 2024 | Quarterly Result Announcement | NA | 05 Nov 2024 | 440.40 | 475.20 |
| 08 Aug 2024 | Annual General Meeting | NA | 08 Aug 2024 | 492.20 | 558.50 |
Announcements
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
6 days ago
6 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 14, 2025
May 14, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 14, 2025
May 14, 2025Announcement under Regulation 30 (LODR)-Investor PresentationMay 13, 2025
May 13, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 13, 2025
May 13, 2025Appointment Of Secretarial Auditors Of The CompanyMay 13, 2025
May 13, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateMay 13, 2025
May 13, 2025Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 13, 2025
May 13, 2025Annual General Meeting On 7Th August 2025May 13, 2025
May 13, 2025Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Financial Year Ended 31St March 2025May 13, 2025
May 13, 2025Board Meeting Outcome for Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Financial Year Ended 31St March 2025May 13, 2025
May 13, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 13, 2025
May 13, 2025Announcement under Regulation 30 (LODR)-Credit RatingMay 13, 2025
May 13, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 09, 2025
May 09, 2025Board Meeting Intimation for Audited Standalone As Well As Consolidated Financial Results For The Quarter And Financial Year Ended 31St March 2025 And Recommendation Of Dividend On Equity Shares If Any For The Financial Year Ended 31St March 2025.May 08, 2025
May 08, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 12, 2025
Apr 12, 2025Closure of Trading WindowMar 27, 2025
Mar 27, 2025Announcement under Regulation 30 (LODR)-AcquisitionFeb 27, 2025
Feb 27, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 17, 2025
Feb 17, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 10, 2025
Feb 10, 2025Announcement under Regulation 30 (LODR)-Investor PresentationFeb 09, 2025
Feb 09, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 08, 2025
Feb 08, 2025Integrated Filing (Financial)Feb 08, 2025
Feb 08, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 07, 2025
Feb 07, 2025Board Meeting Outcome for Un-Audited Standalone As Well As Consolidated Financial Results For The Quarter And Nine Months Ended 31St December 2024Feb 07, 2025
Feb 07, 2025Un-Audited Standalone As Well As Consolidated Financial ResultsFeb 07, 2025
Feb 07, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 04, 2025
Feb 04, 2025Board Meeting Intimation for Inter Alia To Consider Approve And Take On Record The Unaudited Standalone As Well As Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended 3Jan 30, 2025
Jan 30, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 10, 2025
Jan 10, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 02, 2025
Jan 02, 2025Closure of Trading WindowDec 27, 2024
Dec 27, 2024Announcement under Regulation 30 (LODR)-Credit RatingDec 27, 2024
Dec 27, 2024Announcement under Regulation 30 (LODR)-Credit RatingDec 03, 2024
Dec 03, 2024Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 13, 2024
Nov 13, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 06, 2024
Nov 06, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 06, 2024
Nov 06, 2024Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 05, 2024
Nov 05, 2024Announcement under Regulation 30 (LODR)-Investor PresentationNov 05, 2024
Nov 05, 2024Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 30Th September 2024.Nov 05, 2024
Nov 05, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 30, 2024
Oct 30, 2024Board Meeting Intimation for Inter Alia, Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 30Th September, 2024Oct 29, 2024
Oct 29, 2024Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 10, 2024
Oct 10, 2024Closure of Trading WindowSep 26, 2024
Sep 26, 2024Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011Sep 11, 2024
Sep 11, 2024Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Aug 28, 2024
Aug 28, 2024Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 16, 2024
Aug 16, 2024Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Aug 14, 2024
Aug 14, 2024Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportAug 09, 2024
Aug 09, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 08, 2024
Aug 08, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 08, 2024
Aug 08, 2024Technical Indicators
RSI(14)
Neutral 59.02
ATR(14)
Less Volatile 15.15
STOCH(9,6)
Neutral 74.79
STOCH RSI(14)
Overbought 93.02
MACD(12,26)
Bullish 4.07
ADX(14)
Weak Trend 19.80
UO(9)
Bearish 50.90
ROC(12)
Uptrend But Slowing Down 12.14
WillR(14)
Overbought -15.17
Mutual Fund Holdings
| Funding House | No of Shares | Current Holding % | 1M Change % | 3M Change % | Month | |
|---|---|---|---|---|---|---|
 Franklin India Smaller Companies Fund Direct-Growth | 4214678 | 1.38% | -0.15% | -0.13% | Apr 2025 | |
 SBI Small Cap Fund Direct-Growth | 11000000 | 1.42% | -0.13% | -0.14% | Apr 2025 | |
 Axis Small Cap Fund Direct-Growth | 5799329 | 1.02% | -0.09% | -0.10% | Apr 2025 | |
 ICICI Prudential Energy Opportunities Fund Direct-Growth | 1941512 | 0.77% | -0.08% | -0.04% | Apr 2025 | |
 WhiteOak Capital Special Opportunities Fund Direct - Growth | 78306 | 0.38% | -0.06% | -0.07% | Apr 2025 | |
| ICICI Prudential Commodities Fund Direct - Growth | 574618 | 0.90% | -0.06% | -0.07% | Apr 2025 | |
| Franklin India Equity Hybrid Fund Direct-Growth | 255000 | 0.49% | -0.05% | -0.03% | Apr 2025 | |
| ICICI Prudential MNC Fund Direct - Growth | 268762 | 0.69% | -0.05% | -0.02% | Apr 2025 | |
| ICICI Prudential Infrastructure Direct-Growth | 990391 | 0.55% | -0.05% | -0.05% | Apr 2025 | |
| SBI Long Term Equity Fund Direct Plan-Growth | 3714431 | 0.54% | -0.04% | -0.04% | Apr 2025 | |
| Franklin India Balanced Advantage Fund Direct - Growth | 260000 | 0.41% | -0.04% | -0.01% | Apr 2025 | |
| ICICI Prudential Regular Savings Fund Direct-Growth | 399277 | 0.52% | -0.04% | 0.00% | Apr 2025 | |
| ICICI Prudential India Opportunities Fund Direct - Growth | 1875486 | 0.28% | -0.03% | -0.03% | Apr 2025 | |
 Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth | 209863 | 0.44% | -0.03% | 0.44% | Apr 2025 | |
| Franklin India Pension Fund Direct-Growth | 37100 | 0.30% | -0.02% | -0.01% | Apr 2025 | |
| Franklin India Debt Hybrid Fund A Direct- Growth | 10000 | 0.20% | -0.02% | 0.00% | Apr 2025 | |
 Mirae Asset Large Cap Fund Direct- Growth | 2577399 | 0.27% | -0.02% | -0.02% | Apr 2025 | |
| ICICI Prudential Smallcap Fund Direct Plan-Growth | 402246 | 0.22% | -0.02% | -0.04% | Apr 2025 | |
 HDFC Multi Asset Fund Direct-Growth | 200000 | 0.19% | -0.02% | -0.02% | Apr 2025 | |
| SBI Energy Opportunities Fund Direct - Growth | 343380 | 0.14% | -0.01% | -0.02% | Apr 2025 | |
| HDFC Large and Mid Cap Fund Direct- Growth | 198232 | 0.03% | -0.01% | -0.01% | Apr 2025 | |
| ICICI Prudential Multi Asset Fund Direct-Growth | 1264532 | 0.09% | -0.01% | -0.01% | Apr 2025 | |
| HDFC Equity Savings Direct Plan-Growth | 206146 | 0.15% | -0.01% | 0.00% | Apr 2025 | |
| ICICI Prudential Midcap Direct Plan-Growth | 187205 | 0.13% | -0.01% | -0.01% | Apr 2025 | |
 Nippon India Nifty 500 Equal Weight Index Fund Direct-Growth | 0 | 0.00% | -0.01% | -0.20% | Apr 2025 |
About Chemplast Sanmar
Chemplast Sanmar Ltd is an Indian speciality chemicals manufacturer focusing on speciality paste PVC resin and custom manufacturing for pharmaceutical, agro-chemical, and fine chemicals sectors. The company produces chemicals including caustic soda, chlorine, chlorinated solvents, PVC, refrigerant gases, and industrial alcohol. It is the largest manufacturer of speciality paste PVC resin, third largest manufacturer of caustic soda in South India, and one of the oldest manufacturers of Chloromethanes in India. The company has expanded its production capacities over the years and has engaged in various joint ventures and collaborations. In 2018-19, the company underwent restructuring, demerging its Suspension PVC Business and merging with its holding company. Chemplast Sanmar also produces hydrogen peroxide, industrial salt, and custom manufactured chemicals for agrochemical, pharmaceutical, and fine chemical industries.
Listing Date
24 Aug, 2021(3 Years,
34 days)
Chairperson NameVijay Sankar
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
